马斯克回应特斯拉Optimus人形机器人拿下1万台订单：假的！特斯拉市值一夜蒸发超2100亿元

Group 1 - Recent news indicates that PharmAGRI, a U.S. plant-based pharmaceutical company, signed a letter of intent with Tesla to deploy up to 10,000 Optimus Gen3+ humanoid robots in its self-operated farms and prescription drug production, but Elon Musk dismissed this as false on social media [2] - In early September, Tesla's board proposed a new 10-year compensation plan for Musk, potentially worth $1 trillion, contingent on achieving ambitious goals, including selling 1 million AI robots within the decade [5] - Tesla officially launched its "TeslaAI" Weibo account, showcasing its humanoid robots and emphasizing ongoing improvements in their design [6] Group 2 - The humanoid robot features a bionic hand design with realistic details, and Musk anticipates the release of the Optimus Gen3 prototype by the end of this year, with mass production starting in 2026 and a target of 1 million units annually within five years [8] - Tesla's "Master Plan Part IV" signals a strategic shift from electric vehicles and energy products to artificial intelligence and robotics, aiming to integrate AI into real-world products and services for a sustainable future [9] - As of September 18, Tesla's stock closed at $416.85, down 2.12%, with a market capitalization of $1.39 trillion, reflecting a loss of $30 billion in value overnight [9]